Fluindione is under investigation for the treatment of Venous Thrombosis, Pulmonary Embolism, Permanent Atrial Fibrillation, and Anticoagulating Treatment on a Duration at Least 12-month-old Superior. Fluindione has been investigated for the treatment of Blood Coagulation Disorders.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Apixaban | Apixaban may increase the anticoagulant activities of Fluindione. |
| Dabigatran etexilate | Dabigatran etexilate may increase the anticoagulant activities of Fluindione. |
| Dasatinib | The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Fluindione. |
| Deferasirox | The risk or severity of gastrointestinal bleeding can be increased when Fluindione is combined with Deferasirox. |
| Ursodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Ursodeoxycholic acid. |
| Glycochenodeoxycholic Acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Glycochenodeoxycholic Acid. |
| Cholic Acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Cholic Acid. |
| Glycocholic acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Glycocholic acid. |
| Deoxycholic acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Deoxycholic acid. |
| Taurocholic acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Taurocholic acid. |
| Obeticholic acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Obeticholic acid. |
| Chenodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Chenodeoxycholic acid. |
| Taurochenodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Taurochenodeoxycholic acid. |
| Tauroursodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Tauroursodeoxycholic acid. |
| Bamet-UD2 | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Bamet-UD2. |
| Dehydrocholic acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Dehydrocholic acid. |
| Hyodeoxycholic Acid | The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Hyodeoxycholic Acid. |
| Edoxaban | The risk or severity of bleeding can be increased when Edoxaban is combined with Fluindione. |
| Ibrutinib | The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Fluindione. |
| Obinutuzumab | The risk or severity of bleeding and hemorrhage can be increased when Fluindione is combined with Obinutuzumab. |
| Rivaroxaban | Fluindione may increase the anticoagulant activities of Rivaroxaban. |
| Sugammadex | The risk or severity of bleeding and hemorrhage can be increased when Fluindione is combined with Sugammadex. |
| Tibolone | Tibolone may increase the anticoagulant activities of Fluindione. |
| Tipranavir | The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Fluindione. |
| Urokinase | Urokinase may increase the anticoagulant activities of Fluindione. |
| Vitamin E | Vitamin E may increase the anticoagulant activities of Fluindione. |
| Vorapaxar | The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Fluindione. |
| Gemcitabine | The therapeutic efficacy of Fluindione can be increased when used in combination with Gemcitabine. |
| Flunisolide | Flunisolide may increase the anticoagulant activities of Fluindione. |
| Beclomethasone dipropionate | Beclomethasone dipropionate may increase the anticoagulant activities of Fluindione. |
| Betamethasone | Betamethasone may increase the anticoagulant activities of Fluindione. |
| Fluticasone propionate | Fluticasone propionate may increase the anticoagulant activities of Fluindione. |
| Fluocinolone acetonide | Fluocinolone acetonide may increase the anticoagulant activities of Fluindione. |
| Prednisone | Prednisone may increase the anticoagulant activities of Fluindione. |
| Fludrocortisone | Fludrocortisone may increase the anticoagulant activities of Fluindione. |
| Hydrocortisone | Hydrocortisone may increase the anticoagulant activities of Fluindione. |
| Prednisolone | Prednisolone may increase the anticoagulant activities of Fluindione. |
| Methylprednisolone | Methylprednisolone may increase the anticoagulant activities of Fluindione. |
| Trilostane | Trilostane may increase the anticoagulant activities of Fluindione. |
| Budesonide | Budesonide may increase the anticoagulant activities of Fluindione. |
| Dexamethasone | Dexamethasone may increase the anticoagulant activities of Fluindione. |
| Corticotropin | Corticotropin may increase the anticoagulant activities of Fluindione. |
| Cortisone acetate | Cortisone acetate may increase the anticoagulant activities of Fluindione. |
| Paramethasone | Paramethasone may increase the anticoagulant activities of Fluindione. |
| Ciclesonide | Ciclesonide may increase the anticoagulant activities of Fluindione. |
| Aldosterone | Aldosterone may increase the anticoagulant activities of Fluindione. |
| Fluticasone furoate | Fluticasone furoate may increase the anticoagulant activities of Fluindione. |
| Fluprednidene | Fluprednidene may increase the anticoagulant activities of Fluindione. |
| Tixocortol | Tixocortol may increase the anticoagulant activities of Fluindione. |
| Fluprednisolone | Fluprednisolone may increase the anticoagulant activities of Fluindione. |
| Meprednisone | Meprednisone may increase the anticoagulant activities of Fluindione. |
| Dexamethasone isonicotinate | Dexamethasone isonicotinate may increase the anticoagulant activities of Fluindione. |
| Melengestrol | Melengestrol may increase the anticoagulant activities of Fluindione. |
| Deflazacort | Deflazacort may increase the anticoagulant activities of Fluindione. |
| Cortivazol | Cortivazol may increase the anticoagulant activities of Fluindione. |
| Prednylidene | Prednylidene may increase the anticoagulant activities of Fluindione. |
| Fluocortin | Fluocortin may increase the anticoagulant activities of Fluindione. |
| Fluperolone | Fluperolone may increase the anticoagulant activities of Fluindione. |
| Cloprednol | Cloprednol may increase the anticoagulant activities of Fluindione. |
| Fluclorolone | Fluclorolone may increase the anticoagulant activities of Fluindione. |
| Fluticasone | Fluticasone may increase the anticoagulant activities of Fluindione. |
| Mometasone furoate | Mometasone furoate may increase the anticoagulant activities of Fluindione. |
| Hydrocortisone acetate | Hydrocortisone acetate may increase the anticoagulant activities of Fluindione. |
| Hydrocortisone cypionate | Hydrocortisone cypionate may increase the anticoagulant activities of Fluindione. |
| Hydrocortisone succinate | Hydrocortisone succinate may increase the anticoagulant activities of Fluindione. |
| Prednisolone phosphate | Prednisolone phosphate may increase the anticoagulant activities of Fluindione. |
| Prednisolone hemisuccinate | Prednisolone hemisuccinate may increase the anticoagulant activities of Fluindione. |
| Methylprednisolone hemisuccinate | Methylprednisolone hemisuccinate may increase the anticoagulant activities of Fluindione. |
| Prednisone acetate | Prednisone acetate may increase the anticoagulant activities of Fluindione. |
| Clocortolone acetate | Clocortolone acetate may increase the anticoagulant activities of Fluindione. |
| Melengestrol acetate | Melengestrol acetate may increase the anticoagulant activities of Fluindione. |
| Betamethasone phosphate | Betamethasone phosphate may increase the anticoagulant activities of Fluindione. |
| Cortisone | Cortisone may increase the anticoagulant activities of Fluindione. |
| Clobetasol propionate | Clobetasol propionate may increase the anticoagulant activities of Fluindione. |
| Fluocinonide | Fluocinonide may increase the anticoagulant activities of Fluindione. |
| Hydrocortisone butyrate | Hydrocortisone butyrate may increase the anticoagulant activities of Fluindione. |
| Desoximetasone | Desoximetasone may increase the anticoagulant activities of Fluindione. |
| Mometasone | Mometasone may increase the anticoagulant activities of Fluindione. |
| Fluocortolone | Fluocortolone may increase the anticoagulant activities of Fluindione. |
| Prednisolone acetate | Prednisolone acetate may increase the anticoagulant activities of Fluindione. |
| Fluorometholone | Fluorometholone may increase the anticoagulant activities of Fluindione. |
| Difluocortolone | Difluocortolone may increase the anticoagulant activities of Fluindione. |
| Flumethasone | Flumethasone may increase the anticoagulant activities of Fluindione. |
| Methylprednisolone aceponate | Methylprednisolone aceponate may increase the anticoagulant activities of Fluindione. |
| Erlotinib | The serum concentration of Fluindione can be increased when it is combined with Erlotinib. |
| Acetaminophen | Acetaminophen may increase the anticoagulant activities of Fluindione. |
| Allopurinol | The risk or severity of bleeding can be increased when Allopurinol is combined with Fluindione. |
| Azathioprine | The therapeutic efficacy of Fluindione can be decreased when used in combination with Azathioprine. |
| Chloral hydrate | The protein binding of Fluindione can be decreased when combined with Chloral hydrate. |
| Methylphenidate | The metabolism of Fluindione can be decreased when combined with Methylphenidate. |
| Dexmethylphenidate | The metabolism of Fluindione can be decreased when combined with Dexmethylphenidate. |
| Disulfiram | Disulfiram may increase the anticoagulant activities of Fluindione. |
| Etacrynic acid | The protein binding of Fluindione can be decreased when combined with Etacrynic acid. |
| Ethotoin | The therapeutic efficacy of Fluindione can be increased when used in combination with Ethotoin. |
| Etoposide | The therapeutic efficacy of Fluindione can be increased when used in combination with Etoposide. |
| Exenatide | Exenatide can cause an increase in the absorption of Fluindione resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Gefitinib | Gefitinib may increase the anticoagulant activities of Fluindione. |
| Ginkgo biloba | Ginkgo biloba may increase the anticoagulant activities of Fluindione. |
| Glutethimide | The therapeutic efficacy of Fluindione can be decreased when used in combination with Glutethimide. |
| Ifosfamide | The risk or severity of bleeding can be increased when Ifosfamide is combined with Fluindione. |